|
|
||||||||
J Thorac Cardiovasc Surg 1994;108:992-993
© 1994 Mosby, Inc.
LETTERS TO THE EDITOR |
Yale University
New Haven, CT 06510
To the Editor:
I read with great interest the paper by Dr. Macchiarini and his colleagues in Paris describing their direct and effective technical approach to bilateral lung transplantation in patients with Kartagener's syndrome (J THORAC CARDIOVASC SURG 1994;108:86-91).
They describe a sensible approach to cannulation and cardiopulmonary bypass, with cannulation of the ascending aorta, bicaval venous cannulation, and preservation of the drainage from the large azygos vein. In their double lung transplant approach to this disease, they have carefully discussed and described the bronchial surgical anatomy and iterated two important principles. One is the great utility of the approach to the carina between the aorta and superior vena cava. This approach, pioneered by Perelman
1 and others, has been shown to have broad application in the treatment of a variety of lesions, including postpneumonectomy bronchopleural fistula.
2 It is also used in the cardiopulmonary donor operation, because it facilitates the clamping of the trachea well above the carina and permits avoidance of excessive dissection and devascularization of the proximal main stem bronchi.
This leads to the second important principle of this paper, the avoidance of devascularizing the carina, leaving it "with its original vascularization, because it is the milieu at higher risk of ischemia in en bloc DLT with tracheal anastomosis."
The article that they cite to support the importance of collateral circulation in bronchial healing reported a 50% overall incidence of major ischemic airway complications (8 of 16 patients), with 13 tracheal anastomoses (7 complications) and 3 bilateral bronchial anastomoses (1 complication).
3
Because of the early establishment of coronary to bronchial collateral circulation, airway ischemic complications are extremely unusual after combined heart-lung transplantation.
4 Moreover, in contrast to the authors' contention in this article, the risk of cardiac rejection in heart-lung transplantation is small, so that surveillance cardiac biopsies are not required. Thus the advantages of the combined heart-lung approach must be considered against the single legitimate negative concern, the potential "loss" of a donor heart in cases in which heart replacement is not strictly necessitated by the pathophysiology.
In the present allograft era, this is a significant concern. When xenograft strategies are available, the surgical advantages of the combined cardiopulmonary technique may be reconsidered.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |